News
Discover why top-rated corporations like Microsoft and Apple outperform governments in creditworthiness. Click for companies ...
Formycon and its commercialization partner Fresenius Kabi have announced that the US Food and Drug Administration (FDA) has ...
Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds. Based ...
The current earnings multiple is quite low if you take out non-recurring items (NRI). The company now has two operating engines after spinning off consumer brand Kenvue in 2023. Those businesses ...
After the close on Friday, Moody’s dropped a bombshell downgrade of US government debt from AAA to Aa1. But, does it matter?
Uncertainty continues to grip markets as the Donald Trump administration signals a potential return to aggressive trade ...
Cramer noted that investors are skirting Johnson & Johnson (NYSE:JNJ) because of worries regarding Robert Kennedy Jr., as he ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investing.com -- Bayer AG (ETR: BAYGN) is making a renewed effort to resolve the thousands of lawsuits alleging its Roundup weedkiller causes cancer, while simultaneously preparing for a possible ...
Following a third failed bankruptcy maneuver by Johnson & Johnson (NYSE: JNJ), trial lawyers with Dallas-based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer ...
Johnson & Johnson is a dividend king stock whose strong product line and consistency has earned it a listing on the Dow Jones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results